RT Journal Article
SR Electronic
T1 A systematised review of seasonal influenza case-fatality risk
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.22.24315943
DO 10.1101/2024.10.22.24315943
A1 Filipe, Johnny A N
A1 Wong, Carlos K H
A1 van Leeuwen, Edwin
A1 Goodfellow, Lucy
A1 Procter, Simon R
A1 Jit, Mark
YR 2024
UL http://medrxiv.org/content/early/2024/10/30/2024.10.22.24315943.abstract
AB Case-fatality risk (CFR) is an important indicator of disease severity for influenza infection. However, estimates based on laboratory-confirmed cases (cCFR) are more-highly sensitive to features of the local health-care system and surveillance. Estimates based on diagnosed-symptomatic cases (sCFR) are more consistent across health systems but less commonly reported. We present a systematised review of sCFR for seasonal influenza. We identified 10 studies reporting sCFR, or primary data for its direct estimation, resulting in 40 location and season-specific point estimates (range 0.3-908 per 100,000 cases). The wide variation across studies and lack of studies in many world regions point to the need for standardised protocols and more data collection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLG, SP and MJ were supported by the Task Force for Global Health in collaboration with Partnership for Influenza Vaccine Introduction (PIVI). JF, CW and MJ were supported by AIR@InnoHK administered by the Innovation and Technology Commission of the Government of the Hong Kong Special Administrative Region, China, as part of the Laboratory of Data Discovery for Health (D24H). EvL was supported by the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Modelling and Health Economics, a partnership between UKHSA, Imperial College London, and LSHTM (grant number NIHR200908). The views expressed are those of the authors and not necessarily those of the UK Department of Health and Social Care (DHSC), NIHR, or UKHSA.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is a review of peer-reviewed published articles, hence it used only openly available human data located within the literature cited.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes